Pfizer India's profit jumps sevenfold
Pfizer Ltd, the Indian unit of the world's biggest drugmaker, said its second-quarter profit multiplied more than seven times, boosted by about a 13-fold increase in income from businesses other than selling medicines.
By Agencies |
MUMBAI: Pfizer Ltd, the Indian unit of the world's biggest drugmaker, said its second-quarter profit multiplied more than seven times, boosted by about a 13-fold increase in income from businesses other than selling medicines.
Net income rose to RS 2.58 billion ($63 million) in the three months ended May 31, from RS 358.9 million a year earlier, the Mumbai-based company said on Thursday in a statement to the Bombay Stock Exchange.
Earnings from businesses other than medicines, described as ``other income'' in the earnings statement, rose to Rs 2.9 billion from Rs 227.2 million. Aided by other income, revenue more than doubled to Rs 4.56 billion from Rs 1.9 billion.
Net income rose to RS 2.58 billion ($63 million) in the three months ended May 31, from RS 358.9 million a year earlier, the Mumbai-based company said on Thursday in a statement to the Bombay Stock Exchange.
Earnings from businesses other than medicines, described as ``other income'' in the earnings statement, rose to Rs 2.9 billion from Rs 227.2 million. Aided by other income, revenue more than doubled to Rs 4.56 billion from Rs 1.9 billion.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
